Selected article for: "GVHD host versus graft disease and host versus graft"

Author: Timothy A. Dinh; Ramja Sritharan; F. Donelson Smith; Adam B. Francisco; Rosanna K. Ma; Rodica P. Bunaciu; Matt Kanke; Charles G. Danko; Andrew P. Massa; John D. Scott; Praveen Sethupathy
Title: Hotspots of aberrant enhancer activity in fibrolamellar carcinoma reveal molecular mechanisms of oncogenesis and intrinsic drug resistance
  • Document date: 2020_1_18
  • ID: bf4qpsy7_39
    Snippet: In sum, we have used ChRO-seq to map the transcriptional and enhancer landscape of FLC. The genome-scale information provided by ChRO-seq allowed us to identify candidate master transcriptional regulators of FLC and novel candidate FLC oncogenes, demonstrating the power of such genomic approaches. Follow-up functional studies in AML12 cells expressing Dnajb1-Prkaca and a newly derived human FLC cell culture revealed new candidate therapeutic stra.....
    Document: In sum, we have used ChRO-seq to map the transcriptional and enhancer landscape of FLC. The genome-scale information provided by ChRO-seq allowed us to identify candidate master transcriptional regulators of FLC and novel candidate FLC oncogenes, demonstrating the power of such genomic approaches. Follow-up functional studies in AML12 cells expressing Dnajb1-Prkaca and a newly derived human FLC cell culture revealed new candidate therapeutic strategies for FLC.

    Search related documents:
    Co phrase search for related documents
    • cell culture and genome scale: 1
    • cell culture and genomic approach: 1
    • cell culture and novel candidate: 1, 2, 3, 4
    • cell culture and therapeutic strategy: 1, 2, 3, 4, 5, 6
    • ChRO seq and novel candidate: 1
    • functional study and genome scale: 1, 2
    • functional study and genomic approach: 1
    • functional study and new candidate: 1
    • functional study and therapeutic strategy: 1, 2, 3, 4, 5